Therapeutic Potential of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Acute Ischaemic Stroke: Scientific Rationale and Available Evidence

Author： Arthur M. Pancioli

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.18, Iss.14, 2004-01, pp. : 981-988

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in the Management of Ischemic Stroke

By Lapchak P.A. Araujo D.M.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 2, 2003-01 ,pp. : 87-94

Adis International

Access to resources Recommend Favorite

Platelet glycoprotein IIb/IIIa receptor antagonists

By Casserly I.P. Moliterno D.J.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. : 419-433

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of GP IIb/IIIa receptor antagonists in acute myocardial infarction

By Ferguson James J Vaisman Dan

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 11, 2001-11 ,pp. : 1965-1976

Informa Healthcare

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Antagonists in Acute Ischaemic Stroke: Current Status and Future Directions

By Mandava Pitchaiah

Drugs, Vol. 68, Iss. 8, 2008-01 ,pp. : 1019-1028

Adis International

Access to resources Recommend Favorite

Platelet Glycoprotein IIb/IIIa Receptor Antagonists And Their Use In Elderly Patients

By Mak K-H.

Drugs & Aging, Vol. 16, Iss. 3, 2000-03 ,pp. : 179-187

Adis International

Access to resources Recommend Favorite